Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Zhejiang Tongyuankang

Request full access

TOGETHER WE SEARCH FOR THE CURE

Xuhui District, ChinaFounded 2017Biotech & Life Sciences

About Zhejiang Tongyuankang

TyK Medicines, Inc., founded in 2018, is an international biotechnology company based in China, specializing in the research and development of innovative anti-cancer drugs. The company focuses on small molecule oncological immunotherapy, aiming to provide advanced treatment options for cancer patients. TyK Medicines operates in the biopharmaceutical sector, targeting healthcare providers, research institutions, and pharmaceutical companies as its primary clients. The business model revolves around developing proprietary drug candidates and licensing them to larger pharmaceutical firms for commercialization. Revenue is generated through licensing agreements, research grants, and milestone payments. The company leverages a robust technology platform for drug discovery and development, ensuring a pipeline of promising therapeutic candidates. TyK Medicines is committed to advancing the field of oncology through cutting-edge research and strategic collaborations.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
20.7/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
IPOOther financing Aug 2024 $74M $74M Undisclosed ↗
SERIES DOther financing Dec 2023 $28M $275M CICC · Huzhou Talent Innovation Fund · Huiyu Pharmaceutical · Changxing Financial Holdings ↗
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Zhejiang Tongyuankang website traffic

Latest recorded traffic for Zhejiang Tongyuankang is 360 monthly website visits, up 2.9% over the last three months.

Latest monthly visits360 3-month web change+2.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Zhejiang Tongyuankang in the Xuhui District ecosystem

Live from Dealroom

The Zhejiang Tongyuankang office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • Yida China Holdings
  • JunHe
  • Haibang Capital
  • Zheshang Venture Capital

Series B and later8 investors entered at this stage

  • Zhejiang Silk Road Fund
  • Houji Capital
  • Yangtze River Fund
  • Kaicheng Capital
  • CICC
  • Huzhou Talent Innovation Fund
  • Huiyu Pharmaceutical
  • Changxing Financial Holdings
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Xuhui District HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Zhejiang Tongyuankang on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Zhejiang Tongyuankang’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.